Join to view full profile
1275 York AveNew York, NY 10065
Phone+1 646-888-6014
Dr. Lacouture is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mario E. Lacouture, MD
Oncodermatology
Chief, Dermatology Division, Department of Medicine
NYU Grossman Long Island School of Medicine
Medical Director, Symptom Management Program
Perlmutter Cancer Center
NYU Langone Hospital – Long Island
Education & Training
Pontifical Xavierian UniversityClass of 1997
Certifications & Licensure
CA State Medical License 2004 - Present
FL State Medical License 2022 - Present
NY State Medical License 2009 - 2028
CT State Medical License 2023 - 2026
IL State Medical License 2002 - 2011
OH State Medical License 2001 - 2002
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
Publications & Presentations
PubMed
- Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial.Alina Markova, Jelena Ostojić, Veronica Rotemberg, Ian Nykaza, Jad Kanbar
The Lancet. Haematology. 2026-10-01 - Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, David Abramson, Veronica Rotemberg
Nature Medicine. 2026-09-01 - Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.Mario E Lacouture, Alexander Pan, Tara Maier, Anna Chen, George Dranitsaris
Clinical Cancer Research. 2026-08-03
Journal Articles
- https://pubmed.ncbi.nlm.nih.gov/?term=lacouture+m&sort=dateLacouture M, 2023
Press Mentions
AACR: Topical Treatment Offers Relief from Painful Skin Rash Caused by Targeted Cancer TherapyApril 25th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
